A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/12/2002	US6479466 A hydroxylated stilbene that promotes dna synthesis in a virally-targeted cell such as resveratrol; a nucleoside analogue having antiviral activity such as dideoxyinosine
11/12/2002	US6479284 Humanized antibody and uses thereof
11/12/2002	US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002	US6479051 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
11/12/2002	US6479039 Antimicrobial artificial nail composition and methods for preparing and using same
11/12/2002	CA2156486C Mucosal competitive exclusion flora
11/12/2002	CA2099591C 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents
11/12/2002	CA2088917C Therapeutic ribozyme compositions
11/12/2002	CA2077102C Antibiotic ge 2270 factor c2a
11/12/2002	CA2068083C Anti-bacterial compound
11/12/2002	CA2038637C Pharmaceutical iodine compositions
11/07/2002	WO2002088664A2 Control of compactability through crystallization
11/07/2002	WO2002088428A2 Electrolyser with anionic membrane and method for producing a hypochlorite solution using same
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088343A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT)
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088328A2 Method for generating highly active human dendritic cells from monocytes
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	WO2002088177A1 Erav diagnostics and vaccines
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	WO2002088158A1 Process for preparing 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
11/07/2002	WO2002088156A1 Lipid a 1-carboxylic acid derivative
11/07/2002	WO2002088147A1 Sulfate of cephem compound
11/07/2002	WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002	WO2002088127A2 Triazolopyrimidines
11/07/2002	WO2002088124A2 Pyrazolo'1,5-a!pyridine derivatives
11/07/2002	WO2002088122A1 Heterocyclic compounds
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002087615A1 Human polyclonal antibody compositions
11/07/2002	WO2002087614A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002	WO2002087603A1 Immunopotentiators
11/07/2002	WO2002087600A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
11/07/2002	WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002	WO2002087589A1 Medicine for inhibiting drug elimination pump
11/07/2002	WO2002087588A1 Amorphous cefditoren pivoxil composition and process for producing the same
11/07/2002	WO2002087586A1 Sustained release drug delivery system containing codrugs
11/07/2002	WO2002087585A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents
11/07/2002	WO2002087577A1 Medicines
11/07/2002	WO2002087572A1 Triazole derivative solution preparations
11/07/2002	WO2002087570A1 Composition comprising antifungal agents for treating vulvovaginitis and vaginosis
11/07/2002	WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002	WO2002087560A1 Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet
11/07/2002	WO2002087554A2 Ef-tu binding agent as antibacterial agent
11/07/2002	WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002	WO2002087508A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	WO2002087502A2 Antibodies abolish prion propagation and promote clearance of infectivity
11/07/2002	WO2002087465A2 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002087336A1 Foot and mouth disease virus vaccine
11/07/2002	WO2002070537A3 Fusidic acid derivatives
11/07/2002	WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002	WO2002067955A3 A process for the manufacture of a herbal composition comprising a matrine
11/07/2002	WO2002056913A3 Stabilized brivudine topical formulations containing metal oxide pigments
11/07/2002	WO2002056708A3 Preparation for improved dietary utilisation
11/07/2002	WO2002050084A3 Streptogramin derivatives preparation thereof and compositions containing same
11/07/2002	WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002	WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2002012899A3 Peptides presented by cells
11/07/2002	WO2002009768A3 Therapeutic polyesters and polyamides
11/07/2002	WO2002009767A3 Therapeutic polyanhydride compounds for drug delivery
11/07/2002	WO2002009667A3 Dispersions for formulating slightly or poorly soluble active ingredients
11/07/2002	WO2002000613A3 Inhibitors of hepatitis b virus infection
11/07/2002	WO2001048187A9 A molecular switch for regulating mammalian gene expression
11/07/2002	WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002	WO2001037881A9 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
11/07/2002	WO2001034586A3 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
11/07/2002	WO2001027305A9 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
11/07/2002	WO2001027079A9 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
11/07/2002	WO2001010454A9 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
11/07/2002	US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002	US20020165351 Novel compounds
11/07/2002	US20020165343 Growth hormone secretagogues
11/07/2002	US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002	US20020165260 Compositions and methods for the treatment and prevention of bovine mastitis
11/07/2002	US20020165253 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
11/07/2002	US20020165233 Quinoxaline containing medicaments for post exposure prophylaxis of an HIV infection
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165227 Gramnegative bacteria
11/07/2002	US20020165206 Inhibitory or blocking agents of molecular generating and/or inducing functions
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165179 Multifunctional nanodevice platform
11/07/2002	US20020165172 Compositions and methods for treating intracellular diseases
11/07/2002	US20020165168 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/07/2002	US20020165155 Crystallization of IGF-1
11/07/2002	US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002	US20020164787 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
11/07/2002	US20020164770 DNA transfection system for the generation of infectious influenza virus
11/07/2002	US20020164754 Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans
11/07/2002	US20020164722 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002	US20020164625 Compositions isolated from bovine tissues and methods for their use

1 ... 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 ... 1798